Over the years, Dr. Lipov developed a groundbreaking theory on the use of the stellate ganglion block (SGB) to treat PTS. While this procedure, which involves an injection into a cluster of nerves in the neck, has been FDA-approved since the 1950s for other uses, the medical community has been slow to adopt it as a standard treatment for PTS. However, more than 85% of PTS survivors experience immediate relief, and Dr. Lipov has continued to document and refine the procedure since he first performed it in 2006.

His work extends beyond his medical practice. He’s an advocate for reclassifying PTSD as PTSI (Post-Traumatic Stress Injury) and frequently appears in the media to discuss the biological causes and treatment of severe trauma. He has testified before the U.S. House Committee on Veterans’ Affairs and collaborated with neuroscientists to deepen the understanding of the physiological changes behind PTS. His research has been widely published in peer-reviewed medical journals.

In sum, Dr. Lipov can be described as a physician, an advocate, accomplished author (currently writing his third book), public speaker, podcaster, and innovator. If you continue reading, you will learn how my work has served each of his occupations, except for his medical practice.